Interleukin-2 biosimilar (Zenotech Laboratories)

重组人白细胞介素-2生物类似药 (Zenotech Laboratories)

Report date: 2022/02/21 15:13:55

Base Information

Drug NameInterleukin-2 biosimilar (Zenotech Laboratories)
Drug Alias Name重组人白细胞介素-2生物仿制药 (Zenotech Laboratories)Recil
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsCarcinoma, Renal Cell
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2008/03/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesZenotech Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesZenotech Laboratories
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeL03AC01
Related LinksN/A